View in EDS

Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.

Saved in:
Bibliographic Details
Title: Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.
Authors: Hummel M; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany., Hielscher T; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany., Emde-Rajaratnam M; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and St Georg, Hamburg, Germany., Beck S; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Universitätsklinikum Heidelberg, Molekularpathologisches Zentrum, Heidelberg, Germany., Scheid C; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Bertsch U; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany., Goldschmidt H; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Jauch A; Universität Heidelberg, Institut für Humangenetik, Heidelberg, Germany., Moreaux J; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Hose D; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.
Source: JCO precision oncology [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2300613.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38986047
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hummel+M%22">Hummel M</searchLink>; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hielscher+T%22">Hielscher T</searchLink>; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Emde-Rajaratnam+M%22">Emde-Rajaratnam M</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22Salwender+H%22">Salwender H</searchLink>; Asklepios Tumorzentrum Hamburg, AK Altona and St Georg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Beck+S%22">Beck S</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Universitätsklinikum Heidelberg, Molekularpathologisches Zentrum, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Scheid+C%22">Scheid C</searchLink>; Department I of Internal Medicine, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Bertsch+U%22">Bertsch U</searchLink>; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jauch+A%22">Jauch A</searchLink>; Universität Heidelberg, Institut für Humangenetik, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Moreaux+J%22">Moreaux J</searchLink>; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Seckinger+A%22">Seckinger A</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22Hose+D%22">Hose D</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2300613.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4284 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38986047
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/PO.23.00613
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2300613
    Titles:
      – TitleFull: Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hummel M
      – PersonEntity:
          Name:
            NameFull: Hielscher T
      – PersonEntity:
          Name:
            NameFull: Emde-Rajaratnam M
      – PersonEntity:
          Name:
            NameFull: Salwender H
      – PersonEntity:
          Name:
            NameFull: Beck S
      – PersonEntity:
          Name:
            NameFull: Scheid C
      – PersonEntity:
          Name:
            NameFull: Bertsch U
      – PersonEntity:
          Name:
            NameFull: Goldschmidt H
      – PersonEntity:
          Name:
            NameFull: Jauch A
      – PersonEntity:
          Name:
            NameFull: Moreaux J
      – PersonEntity:
          Name:
            NameFull: Seckinger A
      – PersonEntity:
          Name:
            NameFull: Hose D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2473-4284
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: JCO precision oncology
              Type: main
ResultId 1